Ana Rita de Carvalho Acúrcio (8F1C-FAF0-2051)

Curriculum Vitae

Ana Rita de Carvalho Acúrcio

Rita C Acúrcio is currently a Post-Doctoral Fellow at the Research Institute for Medicines (iMedULisboa), integrated in the Faculty of Pharmacy - University of Lisboa. Rita had recently an FCT-funded project as principal investigator (SM-UnLOCK, 50K€) stared in 2022. She is also responsible for a LaCaixa-funded project (CoVax, CF01-00014, 300K€) on the COVID nanomedicine field, at BioNanoSciences - Drug Delivery & Immunoengineering Group. Rita developed her PhD studies in the discovery and development of new small-molecule immune system modulators for cancer treatment. Previously, she developed other projects during her Master Thesis in Organic Chemistry at the University of Aveiro, which resulted in a total of 5 publications in international peer-reviewed journals (two as 1st author). Rita started her PhD in 2016 at Dr. Guedes and Dr. Florindo labs at iMedULisboa (Lisboa, Portugal), which her expertise allowed the development of unique immunomodulatory small molecules to reprogram tumor microenvironment. This technology inspired the FCT-funded project (SM-UnLOCK, 50K€), 3 oral and 10 poster presentations, 3 publications, all as 1st author, 1 Provisional Patent Application (No. 63/150,643), and 1MSc project co-supervised by Rita. In 2020, she started a Post-Doctoral position of a LaCaixa-funded international consortium (NanoPanther, LCF/PR/HR19/52160021, 1M€) on the pancreatic cancer nanomedicine field, involving iMedULisboa (Lisboa, Portugal), Prince Felipe Research Center (CIPF) (Valencia, Spain) and Tel Aviv University (Tel Aviv, Israel). As part of NanoPanther, she joined the Lab of Prof. Ronit Satchi-Fainaro, one of the most renowned groups in Cancer Research and Nanomedicine, at Tel Aviv University (Israel). Overall, Rita interacted with more than 50 authors (+5 nationalities), publishing in total 14 articles and 2 conference proceedings with a cumulative impact factor of 113 and a total of 287 citations. The publication list includes top specialty journals, as Nat. Nanotech., J Med Chem or Adv Drug Deliv Rev. She was also awarded the cover image of the Nat. Nanotech. in August 2020. Rita presented her work at several national/international meetings (7 oral communications and 15 posters). She was supported with 4 travel grants from renowned scientific societies to participate in highly recognized international meetings, including European Association for Cancer Research (EACR) and European Federation for Medicinal Chemistry (EFMC). Also, she was awarded a travel grant by European Commission sponsored COST Mission (CA15135) to enroll in a training school at Fraunhofer-IME, in Hamburg. Rita had been part of the team of 4 FCT-funded projects, 2 international consortiums, and 1 pharmaceutical industry-sponsored project (Polymer Therapeutic Systems (PTS), Valencia, Spain). She is also actively mentoring and/or supervising 2 PhD, 4 MSc students, and 1 Undergraduate student (Research training within Project curricular unit at FFUL).

Ler resumo completo ↓

Identificação

Identificação pessoal

Nome completo: Ana Rita de Carvalho Acúrcio

Nomes de citação

Acúrcio, Rita C

Identificadores de autor

Ciência ID: 8F1C-FAF0-2051
ORCID iD: 0000-0003-3412-1903
Scopus Author Id: 56154070500

Endereços de correio eletrónico

ritaacurcio@ff.ulisboa.pt (Profissional)

Moradas

Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto , 1649-003, Lisbon, Lisbon, Portugal (Profissional)

Domínios de atuação

Ciências Médicas e da Saúde
Ciências Médicas e da Saúde - Biotecnologia Médica
Ciências Médicas e da Saúde - Medicina Clínica - Oncologia
Ciências Exatas - Química - Química Orgânica
Ciências da Engenharia e Tecnologias - Nanotecnologia

Formação

	Grau	Classificação
2016/01/01 - 2019/12/16 Concluído	Pharmacy (Doctor of Philosophy) Especialização em Pharmaceutical and Therapeutic Chemistry Universidade de Lisboa Faculdade de Farmácia, Portugal "Discovery and Development of Novel Small-Molecule Immune System Modulators" (TESE/DISSERTAÇÃO)	Summa cum laude
2018/11/11 - 2018/11/16 Concluído	FLx Flow - Flow Cytometry Course (Outros) Instituto Gulbenkian de Ciência, Portugal
2018/10/01 - 2018/10/04 Concluído	IGC Course on Laboratory Animal Sciences in Mouse and Zebrafish (Outros) Instituto Gulbenkian de Ciência, Portugal
2018/07/01 - 2018/07/05 Concluído	XXXVIII Advanced Course of Medicinal Chemistry and E.Duranti National Seminar for PhD Students (Outros) European School of Medicinal Chemistry , Itália
2012/10 - 2014/07 Concluído	Chemistry (Master) Especialização em Organic Chemistry and Natural Products Universidade de Aveiro, Portugal "Synthesis of new C-glycosyl derivatives " (TESE/DISSERTAÇÃO)	17

Percurso profissional

Ciência

	Categoria Profissional Instituição de acolhimento	Empregador
2020/01/08 - Atual	Pós-doutorado (Investigação)	Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
	Universidade de Lisboa Faculdade de Farmácia, Portugal
2020/01/09 - 2020/07/08	Investigador (Investigação)	Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
	Universidade de Lisboa Faculdade de Farmácia, Portugal
2015/01/02 - 2015/12/31	Investigador (Investigação)	Universidade de Lisboa Faculdade de Farmácia, Portugal
	Universidade de Lisboa Faculdade de Farmácia, Portugal

Outros

	Categoria Profissional Instituição de acolhimento	Empregador
2021/09/07 - 2021/11/22	Visiting researcher at Dr Ronit Satchi-Fainaro Lab (Tel Aviv, Israel) supported with a LaCaixa Post-Doc fellowship from "NanoPanTher", LCF/PR/HR19/52160021	Tel Aviv University Sackler Faculty of Medicine, Israel
	Tel Aviv University Sackler Faculty of Medicine, Israel
2016/01/01 - 2019/12/31	PhD student at Dr Rita Guedes and Dr Helena Florindo Labs (iMedULisboa, Lisboa), supported with a FCT scholarship PD/BD/128238/2016	Universidade de Lisboa Faculdade de Farmácia, Portugal
	Universidade de Lisboa Faculdade de Farmácia, Portugal
2012/02/01 - 2012/07/31	Visiting Undergradute student at Dr Dr. Jordi García Gómez Lab (Barcelona, Spain)	Universitat de Barcelona, Espanha
	Universitat de Barcelona Facultat de Química, Espanha

Projetos

Bolsa

	Designação	Financiadores
2022 - Atual	Next-generation nanomaterials to sensitize breast cancer to immunotherapy UTAP-EXPL/NPN/0041/2021 Investigador Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal The University of Texas at Austin, Estados Unidos	Fundação para a Ciência e a Tecnologia Em curso
2022 - Atual	Multifunctional nano-immunotherapy for melanoma brain metastases treatment PTDC/BTM-SAL/4350/2021 Investigador Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal	Fundação para a Ciência e a Tecnologia Em curso
2022 - Atual	New opportunities for small molecules in immuno-oncology EXPL/MED-QUI/1316/2021 Investigador responsável Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal	Fundação para a Ciência e a Tecnologia Em curso
2020 - Atual	Development of a translational COVID-19 Vaccine CF01-00014 Investigador Pós-doutorado Universidade de Lisboa Faculdade de Farmácia, Portugal Tel Aviv University, Israel	CaixaForum Barcelona Em curso
2020 - Atual	Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines HR18-00589 Bolseiro de Pós-Doutoramento Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal Tel Aviv University Sackler Faculty of Medicine, Israel Centro de Investigacion Principe Felipe, Espanha	CaixaForum Barcelona Em curso
2020 - 2020/06/30	Modulation of melanoma-stroma interactions using a rationally-designed nanomedicine combining BRAFi-, MEKi- and immune-therapies ENMed/0051/2016 Bolseiro de Investigação Universidade de Lisboa Faculdade de Farmácia, Portugal Tel Aviv University, Israel Weizmann Institute of Science, Israel	Fundação para a Ciência e a Tecnologia Em curso
2016 - 2019/12/31	Discovery and Development of New Small-Molecule Immune System Modulators PD/BI/114135/2015 PD/BD/128238/2016 Bolseiro de Doutoramento Universidade de Lisboa Faculdade de Farmácia, Portugal Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal	Fundação para a Ciência e a Tecnologia Concluído
2015 - 2015/12/31	Reactivation of latent HIV-1 by extracellular factors secreted by opportunistic infectious bacteria PEst-OE/SAU/UI0775/2013 Bolseiro de Investigação Universidade de Lisboa Faculdade de Farmácia, Portugal	Fundação para a Ciência e a Tecnologia Concluído

Produções

Publicações

Artigo em revista	Teresa Faria Pais; Hajrabibi Ali; Joana Moreira da Silva; Nádia Duarte; Rita Neres; Chintan Chhatbar; Acúrcio, Rita C; et al. "STING1 activation in brain endothelium by Plasmodium -sequestered heme leads to lethal cerebral malaria through activation of type I IFN response". bioRxiv (Preprint) (2022): Submetido • 10.1101/2022.02.14.480268 "Current hurdles to the translation of nanomedicines from bench to the clinic". Drug Delivery and Translational Research (2021): http://dx.doi.org/10.1007/s13346-021-01024-2. 10.1007/s13346-021-01024-2 Carina Peres; Ana I. Matos; Liane I.F. Moura; Rita C. Acúrcio; Barbara Carreira; Sabina Pozzi; Daniella Vaskovich-Koubi; et al. "Preclinical models and technologies to advance nanovaccine development". Advanced Drug Delivery Reviews 172 (2021): 148-182. https://doi.org/10.1016/j.addr.2021.03.001. 10.1016/j.addr.2021.03.001 Barbara Carreira; Rita C. Acúrcio; Ana I. Matos; Carina Peres; Sabina Pozzi; Daniella Vaskovich-Koubi; Ron Kleiner; et al. "Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment". Advanced Therapeutics 4 1 (2021): 2000147-2000147. https://doi.org/10.1002/adtp.202000147. 10.1002/adtp.202000147 Florindo, H.F.; Kleiner, R.; Vaskovich-Koubi, D.; Acúrcio, R.C.; Carreira, B.; Yeini, E.; Tiram, G.; Liubomirski, Y.; Satchi-Fainaro, R.. "Immune-mediated approaches against COVID-19". Nature Nanotechnology 15 8 (2020): 630-645. http://www.scopus.com/inward/record.url?eid=2-s2.0-85087808917&partnerID=MN8TOARS. 10.1038/s41565-020-0732-3 Acúrcio, R.C.; Scomparin, A.; Satchi-Fainaro, R.; Florindo, H.F.; Guedes, R.C.. "Computer-aided drug design in new druggable targets for the next generation of immune-oncology therapies". Wiley Interdisciplinary Reviews: Computational Molecular Science 9 3 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85055700780&partnerID=MN8TOARS. No prelo • 10.1002/wcms.1397 Acúrcio, R.C.; Leonardo-Sousa, C.; García-Sosa, A.T.; Salvador, J.A.; Florindo, H.F.; Guedes, R.C.. "Structural insights and binding analysis for determining the molecular bases for programmed cell death protein ligand-1 inhibition". MedChemComm 10 10 (2019): 1810-1818. http://www.scopus.com/inward/record.url?eid=2-s2.0-85073807956&partnerID=MN8TOARS. 10.1039/c9md00326f Goncalves, J.; Santos, M.; Acurcio, R.; Iria, I.; Gouveia, L.; Matos Brito, P.; Catarina Cunha-Santos, A.; et al. "Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition". Alimentary Pharmacology & Therapeutics 48 5 (2018): 507-522. http://dx.doi.org/10.1111/apt.14808. No prelo • 10.1111/apt.14808 Acúrcio, R.C.; Scomparin, A.; Conniot, J.; Salvador, J.A.R.; Satchi-Fainaro, R.; Florindo, H.F.; Cardoso Guedes, R.. "Structure-function analysis of immune checkpoint receptors to guide emerging anticancer immunotherapy". Journal of Medicinal Chemistry (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85050352057&partnerID=MN8TOARS. 10.1021/acs.jmedchem.8b00541 Soengas, R.G.; Rodríguez-Solla, H.; Díaz-Pardo, A.; Acúrcio, R.; Concellõn, C.; Del Amo, V.; Silva, A.M.S.. "General preparation of 1-substituted (E)-1,3-dienes under mild conditions". European Journal of Organic Chemistry 2015 11 (2015): 2524-2530. http://www.scopus.com/inward/record.url?eid=2-s2.0-85027934404&partnerID=MN8TOARS. 10.1002/ejoc.201403623 Soengas, Raquel; Silva, Artur; Acúrcio, Rita. "Indium-Mediated Debromination of gem-Bromonitroalkanes under Mild Conditions in Aqueous Medium". Synlett 25 11 (2014): 1561-1564. http://dx.doi.org/10.1055/s-0033-1339030. 10.1055/s-0033-1339030 Soengas, R.G.; Acúrcio, R.; Silva, A.M.S.. "Preparation of indium nitronates and their Henry reactions". Organic and Biomolecular Chemistry 12 43 (2014): 8593-8597. http://www.scopus.com/inward/record.url?eid=2-s2.0-84907966288&partnerID=MN8TOARS. 10.1039/c4ob01468e Soengas, R.G.; Acúrcio, R.C.; Silva, A.M.S.. "Recent developments in the chemistry of gem-halonitro compounds". European Journal of Organic Chemistry 2014 29 (2014): 6339-6359. http://www.scopus.com/inward/record.url?eid=2-s2.0-84957882401&partnerID=MN8TOARS. 10.1002/ejoc.201402043 Acúrcio, R.C.; Soengas, R.G.; Almeida Paz, F.A.; Silva, A.M.S.. "Stereoselective synthesis of orthogonally protected 1,2-diaminoinositols from d -mannose". Synlett 25 15 (2014): 2217-2220. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905326785&partnerID=MN8TOARS. 10.1055/s-0034-1378545
Poster em conferência	Carreira, Bárbara; Acúrcio, Rita C; Liane I. Moura; Ana I. Matos; Sabina Pozzi; Adelaide Fernandes; Sara Xapelli; Ronit Satchi-Fainaro; Helena F Florindo. Autor correspondente: Carreira, Bárbara. "Precision Nanomedicine-based to Regulate Immunsuppression Against Metastatic Melanoma.". Trabalho apresentado em 12th iMed.ULisboa Postgraduate Students Meeting, 2021. Carreira, Bárbara; Acúrcio, Rita C; Adva Krivitsky; Elges Pisarevsky; Ana I. Matos; João M. Conniot; Anna Scomparin; Ronit Satchi-Fainaro; Helena F Florindo. Autor correspondente: Carreira, Bárbara. "Precision Nanomedicine-based Therapeutics to Regulate Immunosuppression Against Melanoma.". Trabalho apresentado em Basic and Translational Research Conference Tumor Microenvironment, 2020. Acúrcio, Rita C; Ana Paula Leandro; Helena F Florindo; Rita C Guedes. "Modulation of PD-1/PD-L1 interaction by small molecules". Trabalho apresentado em 11th iMed.ULisboa Postgraduate Students Meeting & 4th i3DU Meeting,, 2019. Carreira, Bárbara; Anna Scomparin; Adva Krivitsky; Ana I. Matos; Acúrcio, Rita C; João M. Conniot; Ronit Satchi-Fainaro; Helena F Florindo. Autor correspondente: Carreira, Bárbara. "Precision nanotechnology-based therapeutics to regulate tumor-immune cells crosstalk against melanoma.". Trabalho apresentado em 11th iMed.ULisboa Postgraduate Students Meeting & 4rd i3DU Meeting, 2019. Acúrcio, Rita C; Rita C Guedes; Helena F Florindo. "Computational strategy to modulate PD-1/PD-L1 interaction and activate T cells function through small molecules". Trabalho apresentado em 17th Annual Meeting of the Association for Cancer Immunotherapy, 2019. Carreira, Bárbara; Anna Scomparin; Adva Krivitsky; Ana I. Matos; Acúrcio, Rita C; João M. Conniot; Ronit Satchi-Fainaro; Helena F Florindo. Autor correspondente: Carreira, Bárbara. "Precision nanotechnology-based therapeutics to regulate tumor-immune cells crosstalk against melanoma.". Trabalho apresentado em 17th CIMT 2019 Annual Meeting, 2019. Acúrcio, Rita C; Helena F Florindo; Rita C Guedes. "New small-molecule immune checkpoint inhibitors: A new strategy in cancer immunotherapy,". Trabalho apresentado em 2nd Defense is the Best Attack – Immuno-Oncology Breakthroughs, 2019. Acúrcio, Rita C; Helena F Florindo; Rita C Guedes. "Small-molecule immune checkpoint inhibitors: New approach in cancer immunotherapy". Trabalho apresentado em 5th EFMC Young Medicinal Chemist Symposium (EFMC- YMCS), 2018. Acúrcio, Rita C; Helena F Florindo; Rita C Guedes. "Small-molecule immune system modulators: A step forward in cancer immunotherapy". Trabalho apresentado em 10th iMed.ULisboa Postgraduate Students Meeting & 3rd i3DU Meeting, 2018. Acúrcio, Rita C; Helena F Florindo; Rita C Guedes. "Discovery and development of small-molecule immune system modulators". Trabalho apresentado em European School of Medicinal Chemistry (XXXVIII Advanced Course of Medicinal Chemistry and “E.Duranti” National Seminar for PhD Students), 2018. Acúrcio, Rita C; Jorge AR Salvador; Helena F Florindo; Rita C Guedes. "Small-molecule immune checkpoint blockade: New approach in cancer immunotherapy". Trabalho apresentado em 3rd meeting of CQUL - Chemistry at ULisboa & 2018 Summer School,, 2018. Acúrcio, Rita C; Jorge AR Salvador; Helena F Florindo; Rita C Guedes. "Small-molecule immune system modulators: An in silico strategy for cancer immunotherapy". Trabalho apresentado em UL Chemistry PhD Meeting, 2nd Meeting of the CQUL (2ECQUL), 2017. Acúrcio, Rita C; Jorge AR Salvador; Rita C Guedes; Helena F Florindo. "Small-molecule immune system modulators: A step forward in cancer immunotherapy". Trabalho apresentado em Defense is the Best Attack – Immuno-Oncology Breakthroughs,, 2017. Acúrcio, Rita C; Jorge AR Salvador; Helena F Florindo; Rita C Guedes. "Structural insights on imune checkpoint blockade: An in silico strategy towards cancer immunotherapy". Trabalho apresentado em XXV Encontro Nacional da Sociedade Portuguesa de Química, 2017. Acúrcio, Rita C; Pedro Perdigão; Aida Duarte; Carlos São-José; Mariana Santa-Marta; José Moniz-Pereira; João Gonçalves. Autor correspondente: Acúrcio, Rita C. "HIV-1 latency reactivation by bacterial molecular agents derived from opportunistic infections". Trabalho apresentado em 7th iMed.ULisboa Postgraduate Students Meeting, 2015.
Resumo em conferência	Acúrcio, Rita C; Sabina Pozzi; Carreira, Bárbara; Pojo, Marta; Sandra Casemiro; Paula Leandro; Adelaide Fernandes; et al. "Immune Checkpoint Blockade by Novel Small-Molecule Inhibitors Restores T Cell Function". Trabalho apresentado em 1st Spring Virtual Meeting on Medicinal Chemistry, 2021. Publicado • https://doi.org/10.3390/chemproc2021004001 J. Gonçalves; M. Santos; Acúrcio, Rita C; I. Iria; P. Brito; A. C. Cunha Santos; A. Barbas; et al. Autor correspondente: J. Gonçalves. "P545 Antigenic response to CT-P13 and remicade in inflammatory bowel disease patients shows similar epitope recognition". Trabalho apresentado em 13th Congress of ECCO – European Crohn’s and Colitis Organisation, Vienna, 2018. Publicado • 10.1093/ecco-jcc/jjx180.672
Tese / Dissertação	"Discovery and development of new small-molecule immune system modulators". Doutoramento, Universidade de Lisboa Faculdade de Farmácia, 2019. "Synthesis of new C-glycosyl derivatives". Mestrado, Universidade de Aveiro Unidade de Investigação de Química Orgânica Produtos Naturais e Agroalimentares, 2014.

Propriedade Intelectual

Pedido provisório de patente

2021. "Small molecules as modulators of PD-L1/PD-1 interaction".
Protegido

Atividades

Apresentação oral de trabalho

	Título da apresentação	Nome do evento Anfitrião (Local do evento)
2022/01/27	Peptide nano-vaccine against SARS-CoV-2 infection	XVth Spanish Portuguese Conference on Controlled Drug Delivery Spanish Portuguese Conference on Controlled Drug Delivery (Tenerife, Espanha)
2021/11/30	Precision Nanomedicine-based Immunotherapy to Overcome Immunosupression Against Melanoma Brain Metastasis.	5ª conferência da redeSAÚDE (Lisbon, Portugal)
2021/10/15	Precision Multifunctional Nanomedicines to Regulate Immunsuppression Against Melanoma Brain Metastasis.	Cutaneous Melanoma: From where to where? Liga Portuguesa Contra o Cancro (LPCC) (Lisbon, Portugal)
2020/01/24	Precision Nanomedicine-based Therapeutics to Regulate Immunosuppression Against Melanoma	Spanish-Portuguese XIIIth Spanish-Portuguese Conference on Controlled Drug Delivery (Santiago de Compostela, Espanha)
2018/09/03	New small-molecule immune checkpoint inhibitors: A step forward in cancer immunotherapy	XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC) (Liubliana, Eslovénia)
2018/05/16	New small-molecule immune system modulators towards cancer immunotherapy	6th Portuguese Young Chemistry Meeting (PYCheM) (Setúbal , Portugal)
2017/12/04	Small-molecule immune system modulators: An in silico strategy towards cancer immunotherapy	CQUL - UL Chemistry PhD Meeting (2ECQUL) (Lisboa, Portugal)

Orientação

	Título / Tema Papel desempenhado	Curso (Tipo) Instituição / Organização
2022/02 - Atual	Assessment of P32 and Cathepsin S role in Pancreatic Cancer Coorientador de Ana Marta Nunes	Pharmaceutical Sciences (Curso de aperfeiçoamento / especialização) Universidade de Lisboa Faculdade de Farmácia, Portugal
2022/01 - Atual	FAK impact on lymphatic vasculature in metastatic breast cancer Coorientador de Raquel Gouveia	M.Sc. in BioPharmaceutical Sciences (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2021/09 - Atual	Regulating Immune Response Against Pancreatic Cancer Coorientador de Nicole Mendes	M.Sc. in BioPharmaceutical Sciences (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2021/09 - Atual	Deciphering melanoma stroma to improve immunotherapy efficacy Coorientador de Jéssica Luís	Pharmaceutical Sciences (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2019/09 - Atual	Monoclonal Antibodies and Small Molecules Landscape in Cancer Therapy Coorientador	Biopharmaceutical Sciences Master (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal
2019/09 - 2020/07	Small molecules for cancer immunotherapy: A melanoma approach Coorientador	M.Sc. in BioPharmaceutical Sciences (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal

Participação em evento

	Descrição da atividade Tipo de evento	Nome do evento Instituição / Organização
2018/06/18 - 2018/06/22	MedChemTrain Summer School Outro	Frontiers in Medicinal Chemistry - MedChemTrain Summer School Universidade de Lisboa Faculdade de Farmácia, Portugal Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2017/06/12 - 2017/06/16	MedChemTrain Summer School Outro	Frontiers in Medicinal Chemistry - MedChemTrain Summer School Universidade de Lisboa Faculdade de Farmácia, Portugal Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2016/06/20 - 2016/06/24	MedChemTrain Summer School Outro	Frontiers in Medicinal Chemistry - MedChemTrain Summer School Universidade de Lisboa Faculdade de Farmácia, Portugal Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal

Júri de grau académico

	Tema Tipo de participação	Nome do candidato (Tipo de grau) Instituição / Organização
2021/02/26	Small-molecules for Cancer Immunotherapy: A melanoma approach Arguente	Lara Inês Silva Serronha (Mestrado) Universidade de Lisboa Faculdade de Farmácia, Portugal

Arbitragem científica em revista

	Nome da revista (ISSN)	Editora
2021/01/31 - Atual	Drug Delivery and Translational Research	Springer Nature (New York, US)

Curso / Disciplina lecionado

	Disciplina	Curso (Tipo)	Instituição / Organização
2022/02 - Atual	Curricular Unit Pharmaceutical Technology III	Pharmaceutical Sciences (Mestrado integrado)	Universidade de Lisboa Faculdade de Farmácia, Portugal

Membro de associação

	Nome da associação	Tipo de participação
2022/01 - Atual	Spanish-Portuguese Local Chapter Controlled Release Society	Member
2017 - Atual	European Association for Cancer Research (EACR)	Member
2016 - Atual	Sociedade Portuguesa de Química	Member
2016 - Atual	European Federation for Medicinal Chemistry (EFMC)	Member

Outro júri / avaliação

	Descrição da atividade	Instituição / Organização
2021 - Atual	PhD Thesis Committee - PhD Candidate: Silvestre Isidoro	Universidade de Lisboa Faculdade de Farmácia, Portugal
2020/12/17 - 2020/12/17	Jury member of the curricular unit Project III of Integrated Master's in Pharmaceutical Sciences (MICF) at Universidade de Lisboa, Faculdade de Farmácia.	Universidade de Lisboa Faculdade de Farmácia, Portugal

Distinções

Prémio

2019	Travel Grant for Congress "17th Annual Meeting of the Association for Cancer Immunotherapy", 21-23 May, 2019, Mainz, Germany. Association for Cancer Immunotherapy , Alemanha
2019	Inclusiveness Target Countries (ITC) Conference Grants European Cooperation in Science and Technology, Bélgica
2018	Travel Grant for "3rd MuTaLig COST Action Training School" European Cooperation in Science and Technology, Bélgica
2018	Travel Grant to "European School of Medicinal Chemistry ESMEC XXXVIII Advanced Course of Medicinal Chemistry and Seminar for PhD students Urbino, Palazzo Battiferri, July 1-5, 2018" European Federation for Medicinal Chemistry, Suiça
2017	Travel Grant for Congress "Defence is the best attack: Immuno-Oncology Breakthroughs", 9-11 October, 2017, Barcelona. European Association For Cancer Research, Reino Unido

Outra distinção

2020	Nature Nanotechnology Cover (August 2020)
2018	Top 3 Project BioSolveIT Challenge 2018 BioSolveIT GmbH, Alemanha